Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
5
56%
Ph early_phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(2)
Terminated(4)
Other(1)

Detailed Status

Terminated3
Completed2
Not yet recruiting2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
40.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

completed222%
not_yet_recruiting222%
unknown111%
withdrawn111%
terminated333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9